Insights

Competitive intelligence and landscape assessment for an established product used across a variety of neurological indications

PMAS

Our Pricing and Market Access Simulator (PMAS) provides insight into payer willingness-to-pay dynamics, empowering informed access and pricing strategies

Payer Database

Our in-house payer and clinical opinion leader database enables us to quickly and accurately identify the right stakeholders, we provide high-quality insights grounded in real-world expertise

Reflections on Payer Engagement: What we got right — and what’s changed since 2020

Specialized and standard nutritional formulas for the dietary management of pediatric patients with Crohn’s disease: a systematic literature review

Early global landscape assessment to identify the most appropriate launch indications for an early phase asset in neuroscience

Development and delivery of a tender excellence summit to ensure optimal tender management aligned to tender frameworks

Preparing for the impact of ESG

Developing an objection handler to support negotiations for an asset in oncology and optimise pricing and reimbursement outcomes in Europe

Embracing Environmental Sustainability in Healthcare

The shift toward sustainability in pharmaceutical procurement and why ESG investment is no longer optional

Dr. Stefan Walzer, together with Gerdi Strydom, explore the integration of ESG (Environmental, Social, and Governance) into Health

Negotiation program to prepare global affiliates for product launch, and defending launch position from the likely aggressive entry of multiple competitors